Krebs Biochemicals Experiences Significant Volatility Amid Declining Investor Participation
Krebs Biochemicals & Industries Ltd experienced significant stock activity today, hitting the upper circuit limit at 78.33. Despite a last traded price of 74.00, the stock showed notable volatility and underperformed its sector. Investor participation declined, with a drop in delivery volume compared to recent averages.
Krebs Biochemicals & Industries Ltd, a microcap player in the Pharmaceuticals & Drugs sector, has made headlines today as its stock hit the upper circuit limit, reaching a high price of 78.33. Despite a last traded price of 74.00, the stock's performance reflects notable volatility, with a change of -0.6 and a percentage change of -0.8. The stock traded within a price band of 5%, with an intraday low of 73.46. Total traded volume was recorded at 0.0028 lakhs, resulting in a turnover of 0.002093 crore. The stock's performance today underperformed the sector by 0.7%, and it is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages.
Investor participation appears to be declining, with delivery volume dropping by 12% compared to the 5-day average. The liquidity of the stock remains adequate for trading, based on 2% of the 5-day average traded value.
In summary, Krebs Biochemicals & Industries Ltd has shown significant activity today, marked by its upper circuit limit achievement, while also reflecting broader market trends and performance indicators.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
